These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21505715)

  • 1. Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks.
    Gurbel PA; Mahla E; Tantry US
    Thromb Haemost; 2011 Aug; 106(2):248-52. PubMed ID: 21505715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
    Gurbel PA; Tantry US
    Thromb Haemost; 2011 Aug; 106(2):265-71. PubMed ID: 21713326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function testing and prediction of procedural bleeding risk.
    Grove EL; Hossain R; Storey RF
    Thromb Haemost; 2013 May; 109(5):817-24. PubMed ID: 23467639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of platelet function testing in PCI and CABG patients.
    Janssen PW; ten Berg JM; Hackeng CM
    Blood Rev; 2014 May; 28(3):109-21. PubMed ID: 24745727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring platelet function to reduce the risk of ischemic and bleeding complications.
    Price MJ
    Am J Cardiol; 2009 Feb; 103(3 Suppl):35A-39A. PubMed ID: 19166711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
    Maltais S; Perrault LP; Do QB
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
    Metzler H; Prüller F; Münch A; Primus G; Kainz J; Hödl R; Rehak P
    Eur J Anaesthesiol; 2010 Feb; 27(2):138-45. PubMed ID: 19593147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
    Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
    Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
    Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target.
    Gurbel PA; Antonino MJ; Bliden KP; Dichiara J; Suarez TA; Singla A; Tantry US
    Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monitoring for PCI: is it really necessary?
    Tantry US; Gurbel PA
    Hamostaseologie; 2009 Nov; 29(4):368-75. PubMed ID: 19882080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
    Kapetanakis EI; Medlam DA; Boyce SW; Haile E; Hill PC; Dullum MK; Bafi AS; Petro KR; Corso PJ
    Eur Heart J; 2005 Mar; 26(6):576-83. PubMed ID: 15723815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting.
    Yu PJ; Cassiere HA; Dellis SL; Manetta F; Stein J; Hartman AR
    J Card Surg; 2014 May; 29(3):312-6. PubMed ID: 24588751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
    Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.